LMR Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
LMR Partners's VRTX Position: Q2 2026 in Review
LMR Partners reduced its Vertex Pharmaceuticals (VRTX) stake by 50% in Q2 2026, selling an estimated $4.38M and leaving 9,962 shares worth $4.95M. The position accounts for 0.02% of the portfolio, ranked #667.
LMR Partners first reported a position in VRTX in Q4 2014 and has held it in 32 quarters since. The position peaked at $37.8M in Q4 2024. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- LMR Partners held 9,962 shares of Vertex Pharmaceuticals worth $4.95M as of Q2 2026.
- LMR Partners sold 9,891 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.38M.
- Vertex Pharmaceuticals made up 0.02% of LMR Partners's portfolio in Q2 2026, its #667 holding.
- LMR Partners first reported a position in Vertex Pharmaceuticals in Q4 2014 and has held it in 32 quarters since.
- LMR Partners's Vertex Pharmaceuticals position peaked at $37.8M in Q4 2024.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.